Dentons has appointed Bratislava-based partner Zuzana Simekova as Co-head of the Europe Life Sciences group, joining Paris-based Partner Jean-Marc Grosperrin, who has led the group since its inception in 2014.
Jean-Marc Grosperrin commented, “Our Europe Life Sciences group has traditionally been built on the strength of our market-leading practice in Paris which has been expanded throughout Europe. As we look to the future, we plan to start a new phase aimed at further strengthening our capabilities across Europe. So I am very pleased to welcome Zuzana, a leading Life Sciences lawyer in the CEE region, to the leadership team.”
Zuzana Simekova commented, “I feel honored to be appointed to this role. Our Europe Life Sciences practice has a very strong standing and I am very much looking forward to enhancing, alongside Jean-Marc and our colleagues, our offering of excellent, full-service support to the clients in this dynamic sector.”
According to Dentons, Simekova has been practicing law for more than 15 years and focuses primarily on life sciences and competition law. The firm reports that she "advises clients in the pharmaceutical sector in CEE and Europe on a wide range of regulatory issues, including clinical trials, market access, pricing and reimbursement, compliance, distribution and sales models, and advertising. She also has extensive experience in providing regulatory advice and obtaining competition clearance of M&A and corporate transactions in the life sciences sector." According to Dentons, "she has worked for clients such as GE Healthcare, Roche, and Eli Lilly, and recently she advised Sanofi across numerous European countries in relation to the sale of its generic business division in Europe, one of the largest transactions in the life sciences sector in recent years [for] 1.9 million EUR."
Tomasz Dabrowski, CEO of Dentons Europe, commented, “As part of our strategy for Europe, we are committed to enhancing our capabilities in key practices and sectors. Under the capable leadership of Jean-Marc and Zuzana, we will enhance our offering of innovative services and add even more value to our clients in the life sciences sector.”